JSES - 2026-06-18 - Journal Article
Evaluation of new normal after shoulder arthroplasty: comparison of anatomic vs. reverse total shoulder arthroplasty.
Beleckas CM, Schodlbauer DF, Mousad AD, Levy JC
Topics
Key Takeaway
Among shoulder arthroplasty patients achieving a SANE score ≥95, aTSA patients outperformed rTSA patients on all higher-demand functional metrics and ROM, and were more likely to reach that threshold (40% vs. 26%).
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study compared functional outcomes between aTSA and rTSA patients who achieved a 'new normal' defined as SANE ≥95 at minimum 2-year follow-up. Among those reaching this threshold (40% aTSA vs. 26% rTSA), aTSA patients demonstrated significantly superior ASES and SST scores, all ROM parameters, and performance on high-demand tasks including lifting 10 lbs, carrying 20 lbs, usual sport, and usual work (all P<0.001). A subanalysis restricted to osteoarthritis with intact cuff confirmed aTSA superiority on higher-demand functional items.
Key Limitation
The retrospective design cannot exclude indication bias, as rTSA patients likely had worse preoperative tissue quality, greater comorbidity burden, and lower functional baselines, which may inherently cap their best achievable outcomes regardless of implant design.
Original Abstract
BACKGROUND
Reports of equivalent patient-reported outcomes between anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA) have contributed to a continued preference of rTSA. Although many surgeons believe that the best aTSA outcome can outperform the best rTSA outcome, this has not yet been demonstrated in the literature. The purpose of this study is to investigate the outcome characteristics of aTSA and rTSA patients who perceive that their shoulder is close to normal, with the hypothesis that aTSA patients will outperform rTSA patients.
METHODS
A retrospective query of our institution's data repository from 2006 to 2021 identified primary anatomic and rTSA patients with minimum 2-year follow-up and who have achieved a "new normal," defined as a most recent Single Assessment Numeric Evaluation score ≥95. aTSA and rTSA patients were compared based on patient-reported outcome measures, range of motion, and satisfaction. Specific patient-reported outcome measure questions representative of higher functional demands were analyzed, and a subset analysis of patients treated for osteoarthritis with an intact rotator cuff was performed.
RESULTS
The query identified 849 aTSA and 745 rTSA patients with minimum 2-year follow-up. Of these, 40% (337) of aTSA and 26% (193) of rTSA patients reached a Single Assessment Numeric Evaluation score ≥95 at most recent follow-up. aTSA significantly outperformed rTSA in total American Shoulder and Elbow Surgeons score (P < .001); ability to reach a high shelf (P < .001), lift 10 pounds (P < .001), and perform usual work and usual sport (P < .001); total Simple Shoulder Test score (P < .001); ability to lift 8 pounds and carry 20 pounds (P < .001); and range of motion including clinician measured elevation, abduction, external rotation, and internal rotation (P < .001). A subanalysis among patients treated for osteoarthritis with an intact rotator cuff produced similar results, with aTSA patients outperforming rTSA patients in many higher demand functions.
CONCLUSION
aTSA patients have a 40% chance of perceiving their shoulder as normal. Among shoulder arthroplasty patients who perceive their shoulder as normal, aTSA patients outperform rTSA patients with better motion and greater ability to return to work, return to sport, and perform higher demand activities without difficulty.